Restrictive cardiomyopathy.pdf - PDF document

!"#$%&'(%)'"*+,-,.,("/,+"-0'"122'223')-",/"+'2-+%.-%4'".1+&%,35,*1-05678)-+,&$.-%,)"!$%&!'()!)*+,-./01!2033/..&&!%-4!5+67/4%&*!-!3/1/3+3!*-.-4&.!809!-!4.-1*-9*!-*+7.!.9-14.%09-,/,!&,%0,-9*/0:9-3;!-B(+5509.!,-9*/070:/4.4!-1*!&,%0,-9*/0:9-5%&9

4!.0!*&BE9030.&!C+-7/.?!6?!*&8/1/1:!-!4&.!08!*&4,9/5./&!.&934!-1*!3&-4+9&3&1.4;�!/1!,01F+1,./01!/.%!-!4?4.&3-./,!-5590-,%!.0!5&98093/1:!-1*BG-,/7/.-.&!.%&!-,,+9-.&!,035-9/401!08!4&9/-7!&,%0,-9*/0:9-34!5&98093&*!/1!5-./&1.4!-.!.%&!4-3&

!09!*/88&9&1.!4/.&4#"#H!I1*J/1,7+*/1:!.%&!&-97?!4.-:&4!08!*/-4.07/,!4!08!*/4&-4&!*&&#x&705;&1.;&#x;0.5;&#x 000;!/.%!10 ./44+&4;!/1!-1!-61093-7!8093!O10�1!-4!-3?70/*!*&504/.4#!$%/4!*0,+3&1.!:/&4!9&,033&1*-./014!809!.%&!/3-:&!-1*!-1

-7?4/4!*-.-4&.!9&C+/9&*!/1!5-./&1.4!6&/1:!-44&44&*!809!K2L!&#x 0.3;&#x 000;/.%!-!5-9./,+7-9!9&8&9&1,&!.0!,-9*/-,!-3?70/*04/4!-1*!.%&!.9-14.%09-,/,!&,%0,-9*/0:9-5%?!590.0,07!5&98093&*!-.!$%&!IQ!R-./01-7!S3?70/*04/4!2&1.9&!JRS2M;!&#x 0.3;&#x 0

00;/.%!&#x 0.3;&#x 000;%03!.%/4!:+/*&7/1&!%-4!6&&1!,0=-+.%09&*!J%..5ATT&#x 0.3;&#x 000;&#x 0.3;&#x 000;&#x 0.3;&#x 000;#+,7#-,#+OT3&*/,/1&T-3?70/*04/4M#!!U%/7&!&,%0,-9*/0:9-5%?!-770&#x 0.3;&#x 000;4!-!,0359&%&14/&!-44&443&1.!/1!K2L;!/.!/4!/3

509.-1.!.0!9&3&36&9!.%&!,0357&3&1.-9?!907&!08!0.%&9!/3-:/1:!30*-7/./&4;!/1,7+*/1:!,-9*/-,!LKP#!!!!!!!!!!!!!S*-5.&*!8903!R/%0?-11050+704!V!W&#x 0.3;&#x 000;-401;!!"#$%&'()*$"#('+)$,)!-.$-'#/0$1#'%.2!J@XXYM!"X;!///@HZ///HH!9+%31+5"P*/05-.%/,!:

'.,)&1+5"P18/7.9-./&!*/409*&94!¥ S3?70/*04/4!¥ S[A!,-9*/-,!/107&3&1.!,03301#!¥ $9-14.%?9&./1!JS$$KMA Kbi$!9/:%.!&1.9/,+7-9!0+.870&#x 0.3;&#x 000;!.9-,.![TK!ES!7&8.T9/:%.!5+7301-9?!-9.&9?!K[TKIT[[T[I!Eb!9/:%.!70&#x 0.3;&#x 000;&9T9/:%.!+55&9T

7&8.!70&#x 0.3;&#x 000;&9T7&8.!+55&9!5+7301-9?!&/1!$b!.9/,+45/*!-7&!Pb2!/18&9/09!&1-!,--!($j!4/10.+6+7-9!F+1,./01![bPW*T4!7&8.!&1.9/,+7-9!/1.&91-7!*/3&14/01!/1!*/-4.07&T4?4.07&!Pb(*T4!/1.&9&1.9/,+7-9!4&5.-7!&#x 0.3;&#x 000;/*.%!/1!*/-4.07&T4

?4.07&![bEU*!7&8.!&1.9/,+7-9!504.&9/09!&#x 0.3;&#x 000;-77!&#x 0.3;&#x 000;/*.%!/1!*/-4.07&!E`$!59&44+9&!%-78=./3&!Kb*!9/:%.!&1.9/,+7-9!,-/.?!*/-3&.&9!/1!*/-4.07&!b$P!&70,/.?!./3&!/1.&:9-7!KULS!9&:/01-7!&#x 0.3;&#x 000;-77!30./01!-61093-7/.?

!$SE()!.9/,+45/*!-11+7-9!57-1&!4?4.07/,!&N,+94/01!LSE() in the mild to moderate range PW TDI Mitral annulus: eÕ eÕ/ aÕ E/eÕ Sept and Lat sÕ In restrictive filling: Restrictive filling pattern with low eÕ eÕ/ aÕ 1 E/eÕ (average

of septal and lateral mitral annulus) &#x 4 ; 13 Earlier in the natural history of restrictive disease, abnormalities of mitral annular PW TDI may be in the mild or moderate categories of diastolic dysfunction. Please refer to the BSE dias

tolic function assessment guidelines Reduced systolic velocity. Reductions in TDI systolic and diastolic indices typically occur earlier in the natural history of PW or CW Doppler IVRT Short IVRT (50ms) is in keeping with severe restri

ctive filling, but in earlier stages of the disease process may b Deformation imaging Global and peak longitudinal systolic strain (optional but extremely useful) Reduced with relative apical sparing, giving rise to a characteristic Ôbull

Õs eyeÕ appearance on speckle tracking software* Ensure high quality, optimized views for speckle tracking post-processing. This should result in a frame rate that is commensurate with optimal speckle tracking (at least � 80 fps) Re

ductions in strain indices typically occur earlier in the natural history of the amyloid disease process than traditional echocardiographic measures, and may be a subclinical marker when this condition is suspected Due to inter-vendor varia